Beckman Coulter Life Sciences Collaborates with genedrive plc to Automate High-Throughput SARS-CoV-2 PCR Testing
Beckman Coulter Life Sciences | August 10, 2020
Beckman Coulter Life Sciences announces that it has entered into a collaboration with genedrive plc (LSE: GDR), the near-patient molecular diagnostics company, to automate the laboratory PCR testing process for COVID-19. The two companies are working to combine and validate the Genedrive® 96 SARS-CoV-2 Kit on the Biomek i7 automated workstation—with saliva samples extracted using Beckman Coulter’s RNAdvance Viral extraction chemistry.